Own the intended use and acceptance
The regulated manufacturer defines applicable markets, product and pack requirements, critical risks, record strategy, validation plan and release authority.
Compliance scope for regulated blister packaging
Blister Packaging GMP Compliance
Define a machine, controls and documentation scope that your quality team can trace from intended use and URS through supplier review, FAT and site qualification.
URS-led scopeRisk-based evidenceFAT traceabilityBuyer-owned validation
A blister machine is not independently “GMP certified.” GMP applies to the regulated manufacturer's quality system, premises, processes, records and continuing control. Equipment can support that system only when its intended use, design features, documentation, testing and site responsibilities are defined and verified.
Start with responsibility
Turn “GMP compliant” into an auditable project boundary
A useful request does not ask a supplier to certify an entire manufacturing site. It states what the blister line will do, which regulated records and quality risks are involved, what evidence the supplier must provide, what the buyer will test, and who has approval authority. That boundary makes offers comparable and prevents a vague compliance label from replacing engineering work.
Provide the agreed machine evidence
The supplier designs and documents the quoted scope, answers the URS, identifies exclusions, supports agreed reviews and executes the approved FAT responsibilities.
Control interfaces and installation
Utilities, line interfaces, networks, user management, environmental conditions and site procedures must be assigned before testing begins.
Approve the lifecycle evidence
The buyer's authorized functions decide whether risk controls, deviations, qualification results and continuing procedures are sufficient for the intended use.
Framework map
Which GMP and electronic-record frameworks belong in the URS?
The answer depends on the product, target market, licensed activities and how the site will use records. The table is a scoping aid, not a legal determination. The buyer's quality and regulatory teams should identify the applicable requirements before a machine configuration is approved.
| Framework | What it governs | Machine-project question | Do not assume |
|---|---|---|---|
| US drug CGMP, 21 CFR Parts 210 and 211 | Manufacturing, processing, packing and holding controls for drugs and finished pharmaceuticals. | Which equipment functions, controls and records support the site's applicable CGMP procedures? | That FDA “certifies” a packaging machine as compliant. |
| FDA 21 CFR Part 11 | Criteria for certain electronic records and electronic signatures used under FDA predicate rules. | Which required records will the site rely on electronically, and which system controls are needed? | That every touchscreen automatically makes Part 11 applicable. |
| EU GMP Volume 4 | The pharmaceutical quality system, premises/equipment, documentation and other GMP expectations; Annex 11 covers computerised systems and Annex 15 covers qualification and validation. | Which URS, lifecycle, data and qualification evidence must be assigned to supplier and buyer? | That a CE mark establishes pharmaceutical GMP compliance. |
| WHO GMP validation guidance | Risk-based qualification and validation principles for premises, equipment, utilities, systems, methods, processes and procedures. | How will the URS remain traceable through design, FAT/SAT where used, IQ, OQ and continuing control? | That one old WHO annex or one material grade is a universal machine certificate. |
Procurement rule: name the exact document, revision or regulatory requirement used by the buyer. A generic list of acronyms in a quotation does not define deliverables or acceptance.
Evidence map
Keep one traceable line from intended use to release
The sequence below is a practical project map. The exact activities, names and order must follow the buyer's quality system and risk assessment. Supplier tests may support qualification, but reuse must be justified and documented.
Intended use and regulatory boundary
Define product, packaging process, operating environment, target markets, record strategy, users and the decisions the system will support.
URS and responsibility matrix
Translate quality risks into testable requirements. Assign each specification, document, interface, test, deviation and approval to supplier or buyer.
Design review and DQ
Review the proposed design against the approved URS. Record accepted alternatives, exclusions and unresolved actions before manufacture progresses.
FAT and shipment evidence
Challenge the configured machine with agreed products, materials, formats, controls and records. Close or formally disposition deviations.
SAT, IQ and OQ
Verify the received configuration, installation, utilities, calibration status, software/version boundary, alarms, operating ranges and site interfaces as applicable.
PQ and continued state of control
The buyer qualifies performance with its product, procedures, personnel and approved protocol, then maintains control through training, calibration, maintenance, backup, review and change management.
Before quotation
Inputs HIJ needs to define the machine and documentation scope
Send the evidence available today and label unknowns. A clear gap is safer than a specification invented to make the RFQ look complete.
- Product and presentation: dosage form, dimensions, fragility, orientation, exposure and contamination risks.
- Pack definition: cavity drawing, forming web, lidding material, print/coding, seal and opening requirements.
- Accepted output: good-pack definition, sustained run period, planned stops, rejects and sampling boundary.
- Target markets: licensed regions and the buyer's applicable GMP or regulatory references.
- Site environment: room classification where applicable, temperature/humidity limits, cleaning approach and utilities.
- Line interfaces: feeders, printers, vision, reject handling, cartoners, conveyors and upstream/downstream signals.
- Record strategy: paper, electronic or hybrid records; authoritative record; retention; review; export and backup needs.
- User and security model: roles, access approval, authentication, authority checks and electronic signatures if used.
- Documentation request: drawings, manuals, certificates, software documents, protocols, reports and required language.
- Validation responsibility: supplier support, buyer execution, acceptance authority, deviation handling and site release.
Design review
Review machine features against product and process risk
GMP guidance does not reduce equipment selection to a universal stainless-steel grade, surface-finish value or checklist. Define the construction and evidence that are appropriate for the actual contact boundary, cleaning method, product risk and site procedure.
Product-contact boundary
Identify direct and indirect contact parts, lubricants, fasteners, guarding and areas where fragments, residues or cleaning agents could affect the product.
Cleanability and access
Define dismantling, cleaning tools, inspection access, line clearance, drainage where relevant and how clean status will be verified.
Process controls
Map forming, feeding, sealing, cooling, registration, cutting, coding, inspection and rejection parameters to the pack's critical requirements.
Calibration and maintenance
Identify instruments and functions that affect quality, then define ranges, accuracy needs, calibration evidence, maintenance access and change control.
Computerised systems
Define Part 11 and Annex 11 needs from the record, not the touchscreen
First identify the records required by applicable rules and decide which record the site will rely on to perform regulated activities. FDA's Part 11 guidance explains that scope depends on predicate-rule records maintained or submitted electronically and on actual business practice. EU GMP Annex 11 applies to computerised systems used in GMP-regulated activities and places lifecycle, risk, supplier and validation responsibilities on the regulated user.
| Decision | Questions for the buyer | Evidence to define with the supplier |
|---|---|---|
| Authoritative record | Which paper or electronic record is relied on for the regulated activity? | Record inventory, data-flow diagram, file/report formats and system boundary. |
| Access and authority | Who may view, operate, change recipes, administer users, review or approve? | Role matrix, authentication method, privilege tests and administrator responsibilities. |
| Audit trail | Which GMP-relevant actions or changes must be captured and reviewed? | Event content, timestamp basis, user attribution, review method, export and retention behavior. |
| Electronic signatures | Will electronic signatures be used as the equivalent of required handwritten signatures? | Signature manifestation, meaning, record linkage and identity-control requirements where applicable. |
| Copies and retention | What must remain readable, complete and retrievable for the required period? | Accurate copy/export tests, metadata, archive format, retrieval and migration responsibility. |
| Backup and recovery | What data can be lost, for how long, and who owns recovery? | Backup scope, frequency, storage, restore test, failure alarms and site infrastructure assumptions. |
| Lifecycle control | How will patches, configuration changes, replacement hardware and periodic review be managed? | Version baseline, change notification, service access, configuration record and support boundary. |
Important: a list of software features is not evidence that the buyer's implemented system complies. Intended use, configuration, procedures, validation, infrastructure and continuing governance remain part of the assessment.
Supplier package
Name every document in the quotation and responsibility matrix
“Validation documentation included” is too vague for procurement. Document availability, format, language, revision, approval status, customization, execution and site support can materially change project scope. Ask suppliers to answer the matrix line by line.
Before purchase orderURS response, scope/exclusion list, preliminary configuration, document index, responsibility matrix and proposed acceptance strategy.
Design stageApproved drawings and specifications, component/option list, control description, software boundary, risk-review inputs and DQ support defined by contract.
Before FATApproved FAT protocol, prerequisites, products/materials, sampling, instruments, acceptance criteria, data capture and deviation workflow.
Before shipmentFAT report and deviations, configuration baseline, manuals, certificates in scope, backups, spare-parts list and open-item register.
At the buyer siteInstallation and commissioning records, IQ/OQ support or templates if contracted, training evidence, SAT activities and handover responsibilities.
During operationService access, change notification, replacement-part traceability, calibration/maintenance information and software-support boundary.
Factory acceptance test
Use FAT to test the quoted configuration and close evidence gaps
FAT should use the approved machine configuration and a defined sample of products, packaging materials and formats. Its purpose is to produce objective evidence against agreed requirements before shipment, while identifying which site-dependent activities remain for SAT and qualification.
- Verify machine, tooling, controls, software and document revision baseline.
- Confirm product and packaging-material identity, lots and usable quantities.
- Test forming, feeding, sealing, registration, coding, inspection and rejection as applicable.
- Challenge alarms, interlocks, user roles, recipes and recovery from defined stops.
- Record good output, rejects, stops, interventions and agreed quality checks.
- Capture raw evidence, deviations, retests, open items, owners and due dates.
- State which FAT tests may support later qualification and why transport/site conditions do not invalidate them.
- Obtain authorized review before shipment; do not treat an unresolved punch list as silent acceptance.
For a broader validation workflow, compare this scope with the blister packaging IQ/OQ/PQ validation page and use the blister machine URS guide to structure requirements.
Avoid weak purchase decisions
Six common GMP-scoping mistakes
Buying a “GMP certificate”
A supplier certificate or label cannot replace the buyer's quality system, intended-use assessment, qualification and continuing control.
Copying universal material specifications
Construction materials and finishes should follow the actual contact boundary, product risk, cleaning method and approved design—not an unsupported global number.
Ordering “Part 11 ready”
Define authoritative records, roles, audit trails, signatures, copies, retention and infrastructure before selecting functions.
Using a fixed validation timeline
Duration depends on scope, site readiness, protocols, product/material availability, deviations and approval resources.
Letting FAT replace site qualification
Supplier testing can support later work only when reuse is justified; installation, utilities, environment and site procedures still matter.
Leaving documents outside the contract
If the quotation does not name the deliverable, format, responsibility and acceptance point, neither party has a reliable scope.
Commercial workflow
What happens after you send the project evidence
Scope review
HIJ reviews the product, pack, target market, site, record strategy and requested documents.
Clarification register
Unknowns, conflicts, buyer decisions and supplier exclusions are returned as visible actions.
Configured proposal
The offer names the machine configuration, interfaces, documentation, responsibilities and assumptions.
Acceptance plan
FAT conditions and evidence are aligned with the approved URS and the site's later qualification strategy.
Best inquiry package: send the current URS or requirement list, product and packaging samples/data, intended markets, line layout, record strategy and desired FAT conditions. If an item is undecided, mark it as open.
Buyer questions
Frequently asked questions
Is a blister packaging machine itself GMP certified?
No single machine certificate establishes a pharmaceutical manufacturer's GMP compliance. The equipment must be specified, installed, operated, maintained and qualified within the buyer's applicable quality system and intended use. Supplier design and documentation can support that work.
Which GMP framework should a blister machine project use?
The buyer should identify requirements from its product, licensed activities and target markets. Relevant sources may include US drug CGMP requirements, EU GMP Volume 4 and WHO GMP guidance. The URS should cite the exact requirements the project will apply.
Is AISI 316L required for every blister packaging machine surface?
No universal statement should replace a product-contact and risk assessment. Define direct and indirect contact parts, material compatibility, cleanability, corrosion risk, cleaning agents and certificate needs for the intended process. Non-contact construction may have different requirements.
Does every PLC or touchscreen need 21 CFR Part 11 functions?
Not automatically. First determine which records are required by applicable FDA predicate rules and whether the site relies on them electronically. Then define the relevant system controls, validation and procedures. A touchscreen alone does not determine Part 11 scope.
What supplier documents should be requested before ordering?
Request a URS response, configuration and exclusion list, document index, responsibility matrix and proposed FAT boundary. Drawings, manuals, certificates, software documents and qualification support should be named individually where required.
Can FAT replace IQ, OQ or PQ at the buyer's site?
FAT can provide useful supplier evidence, and some tests may be reused when justified and when transport or installation cannot affect the verified function. The buyer must decide and document reuse within its validation system. Site installation, utilities, interfaces and routine production conditions still require appropriate evaluation.
How long does blister machine qualification take?
There is no defensible universal duration. Timing depends on project scope, site readiness, approved protocols, product and packaging-material availability, deviations, training and review resources. Build the schedule from these prerequisites rather than a generic week range.
Who approves final GMP compliance and release for use?
The regulated manufacturer retains responsibility for its GMP system and for approving qualification, deviations, procedures and release according to its authorized governance. A machine supplier may provide contracted evidence and support, but cannot approve the buyer's site or process on the buyer's behalf.
Primary regulatory sources used for this scope
- FDA: Current Good Manufacturing Practice regulations — overview and links for 21 CFR Parts 210 and 211.
- FDA: Part 11, Electronic Records; Electronic Signatures — Scope and Application.
- European Commission: EudraLex Volume 4 — including Chapter 3, Chapter 4, Annex 11 and Annex 15.
- WHO TRS 1019, Annex 3: GMP guidelines on validation.
Regulatory requirements and guidance can change. Confirm the current official text, applicable product authorization and local authority expectations before approval. This page supports equipment-scoping discussions and is not legal or regulatory advice.
Define the evidence before the price
Request a traceable GMP machine scope
Send your intended use, product and pack definition, target markets, record strategy, URS or requirement list, site interfaces and expected FAT evidence. HIJ can return a clarification list and a proposal boundary for technical and quality review.